Author: Fei Xiao; Meiwen Tang; Xiaobin Zheng; Chunna Li; Jianzhong He; Zhongsi Hong; Siwen Huang; Zhenyi Zhang; Xianqi Lin; Zhaoxiong Fang; Renxu Lai; Shoudeng Chen; Jing Liu; Jin Huang; Jinyu Xia; Zhonghe Li; Guanmin Jiang; Ye Liu; Xiaofeng Li; Hong Shan
Title: Evidence for gastrointestinal infection of SARS-CoV-2 Document date: 2020_2_20
ID: 7odpslba_7
Snippet: The copyright holder for this preprint . https://doi.org/10.1101/2020.02.17.20023721 doi: medRxiv preprint specific target cells or organs are determinants of viral transmission routes. 146 Receptor-dependent viral entry is the first step of SARS-CoV-2 infection. Our 147 immunofluorescent data showed that ACE2 protein, which has been proved to be the CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has .....
Document: The copyright holder for this preprint . https://doi.org/10.1101/2020.02.17.20023721 doi: medRxiv preprint specific target cells or organs are determinants of viral transmission routes. 146 Receptor-dependent viral entry is the first step of SARS-CoV-2 infection. Our 147 immunofluorescent data showed that ACE2 protein, which has been proved to be the CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- available International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- available International license and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- available International license and transmission route: 1, 2, 3, 4
- available International license and viral entry: 1, 2, 3, 4, 5, 6, 7
- available International license and viral transmission route: 1
- cc NC ND available International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc NC ND available International license and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc NC ND available International license and transmission route: 1, 2, 3
- cc NC ND available International license and viral entry: 1, 2, 3, 4, 5
- International license and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- International license and target cell: 1, 2
- International license and transmission route: 1, 2, 3, 4
- International license and viral entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- International license and viral transmission route: 1
- receptor dependent viral entry and SARS infection: 1
- receptor dependent viral entry and viral entry: 1, 2, 3, 4, 5, 6
- SARS infection and specific target cell: 1, 2, 3, 4, 5, 6, 7, 8
- SARS infection and target cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- SARS infection and transmission route: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date